Literature DB >> 18570593

Hepatitis C virus core protein discriminates between the two IgG2 allotypes.

Aryan M Namboodiri1, Paul J Nietert, Janardan P Pandey.   

Abstract

Immunoglobulin GM allotypes, genetic markers of IgG, are associated with the outcome of hepatitis C virus (HCV) infection, but the underlying mechanisms are not completely understood. HCV has evolved mechanisms for decreasing the efficacy of the host immune response. One such strategy might involve the scavenging of the Fcgamma domain of the anti-HCV IgG antibodies by its Fcgamma -receptor-like core protein and thus interfering with the Fcgamma -mediated host defense mechanisms. We tested the hypothesis that GM allotypes modulate this viral strategy through differential binding to the core protein. Here we show that the absorbance values for binding to the core protein were higher for GM23+IgG2 than for GM23-IgG2 (p = 0.027), a finding that at least in part explains the involvement of GM allotypes in the outcome of HCV infection. These findings also contribute toward our understanding of the mechanisms that maintain strong linkage disequilibrium between particular GM alleles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18570593      PMCID: PMC2712350          DOI: 10.1089/vim.2008.0008

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  11 in total

1.  Humoral immunity in acute and chronic hepatitis C infection.

Authors:  N N Zein; H Li; D H Persing
Journal:  Gastroenterology       Date:  1999-08       Impact factor: 22.682

2.  High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R.

Authors:  R L Shields; A K Namenuk; K Hong; Y G Meng; J Rae; J Briggs; D Xie; J Lai; A Stadlen; B Li; J A Fox; L G Presta
Journal:  J Biol Chem       Date:  2000-11-28       Impact factor: 5.157

3.  Limited humoral immunity in hepatitis C virus infection.

Authors:  M Chen; M Sällberg; A Sönnerborg; O Weiland; L Mattsson; L Jin; A Birkett; D Peterson; D R Milich
Journal:  Gastroenterology       Date:  1999-01       Impact factor: 22.682

Review 4.  Immunogenetics of viral infections.

Authors:  Maureen P Martin; Mary Carrington
Journal:  Curr Opin Immunol       Date:  2005-10       Impact factor: 7.486

5.  A new rapid method for genetic typing of human immunoglobulins.

Authors:  G N Vyas; H H Fudenberg; H M Pretty; E R Gold
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

Review 6.  Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection.

Authors:  Andrew R Lloyd; Emma Jagger; Jeffrey J Post; Lee-Ann Crooks; William D Rawlinson; Young S Hahn; Rosemary A Ffrench
Journal:  Immunol Cell Biol       Date:  2006-11-28       Impact factor: 5.126

7.  A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.

Authors:  I Frank; H M Friedman
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virus.

Authors:  Janardan P Pandey; Jacquie Astemborski; David L Thomas
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Fc gamma receptor-like hepatitis C virus core protein binds differentially to IgG of discordant Fc (GM) genotypes.

Authors:  Aryan M Namboodiri; Agata Budkowska; Paul J Nietert; Janardan P Pandey
Journal:  Mol Immunol       Date:  2007-05-07       Impact factor: 4.407

10.  Fcgamma receptor-like activity of hepatitis C virus core protein.

Authors:  Patrick Maillard; Jean-Pierre Lavergne; Sophie Sibéril; Grazyna Faure; Farzin Roohvand; Stephane Petres; Jean Luc Teillaud; Agata Budkowska
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

View more
  3 in total

1.  Genetic markers of IgG influence the outcome of infection with hepatitis C virus.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Yuqun Luo; Yuping Wu; Robert C Elston; David L Thomas; Hugo R Rosen; James J Goedert
Journal:  J Infect Dis       Date:  2008-11-01       Impact factor: 5.226

2.  The forgotten tale of immunoglobulin allotypes in cancer risk and treatment.

Authors:  Janardan P Pandey; Zihai Li
Journal:  Exp Hematol Oncol       Date:  2013-02-20

Review 3.  Beyond Allotypes: The Influence of Allelic Diversity in Antibody Constant Domains.

Authors:  Annmaree K Warrender; William Kelton
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.